| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |